Arcutis Biotherapeutics, Inc.ARQTNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Loading chart...

Alerts

Want to monitor ARQT?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor ARQT

Key Statistics

About

Arcutis Biotherapeutics, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. The company is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin.

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

arcutis.com →

News

BYND Investors Have Opportunity to Lead Beyond Meat, Inc. Securities Fraud Lawsuit

prnewswire.com

Columbia Sportswear's Plunge Doesn't Make The Stock A Good Fit

seekingalpha.com

A Generational Lithium Franchise in the Making: Elektros Inc. Elevates Institutional-Grade Investor Communications to Advance Critical Minerals Growth

accessnewswire.com

ARDT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health

newsfilecorp.com

Is This Short-Term Bond ETF a Buy After Merit Financial Bought Shares Worth $8.6 Million?

fool.com

Is UPS Stock a Buy Now?

fool.com

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BellRing Brands, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BRBR

globenewswire.com

Oracle amps up its AI bet with a plan to raise as much as $50 billion this year

marketwatch.com

AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics

newsfilecorp.com

SBC Medical-Supported Medical Corporation Nasukai Forms Strategic Alliance with Daibi Medical Aesthetics

prnewswire.com

AAR Corp.: Well Positioned To Capitalize On Current Demand/Supply Dynamic

seekingalpha.com

Why AT&T Stock Surged This Week

fool.com

Disney may soon have a new CEO. Here's who it might be.

marketwatch.com

This Dirt Cheap Stock Is Expected to Quadruple Its Earnings This Year

fool.com

OWL INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue Owl Capital

newsfilecorp.com

Forget Tech Stocks: The Utility That's Solving AI's Biggest Problem

fool.com

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

Key Statistics

About

News

BYND Investors Have Opportunity to Lead Beyond Meat, Inc. Securities Fraud Lawsuit

Columbia Sportswear's Plunge Doesn't Make The Stock A Good Fit

A Generational Lithium Franchise in the Making: Elektros Inc. Elevates Institutional-Grade Investor Communications to Advance Critical Minerals Growth

ARDT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health

Nova Eye Medical Limited (ELXMF) Q2 2026 Earnings Call Transcript

3 Reasons to Buy Uber Stock Like There's No Tomorrow

Apple Loses More AI Researchers to Meta and Google

A March Decision That Could Change Protalix BioTherapeutics Outlook

Is This Short-Term Bond ETF a Buy After Merit Financial Bought Shares Worth $8.6 Million?

Is UPS Stock a Buy Now?

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BellRing Brands, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BRBR

Oracle amps up its AI bet with a plan to raise as much as $50 billion this year

AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics

SBC Medical-Supported Medical Corporation Nasukai Forms Strategic Alliance with Daibi Medical Aesthetics

AAR Corp.: Well Positioned To Capitalize On Current Demand/Supply Dynamic

Why AT&T Stock Surged This Week

Disney may soon have a new CEO. Here's who it might be.

This Dirt Cheap Stock Is Expected to Quadruple Its Earnings This Year

OWL INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue Owl Capital

Forget Tech Stocks: The Utility That's Solving AI's Biggest Problem

Explore More

BYND Investors Have Opportunity to Lead Beyond Meat, Inc. Securities Fraud Lawsuit

Columbia Sportswear's Plunge Doesn't Make The Stock A Good Fit

A Generational Lithium Franchise in the Making: Elektros Inc. Elevates Institutional-Grade Investor Communications to Advance Critical Minerals Growth

ARDT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health

Nova Eye Medical Limited (ELXMF) Q2 2026 Earnings Call Transcript

3 Reasons to Buy Uber Stock Like There's No Tomorrow

Apple Loses More AI Researchers to Meta and Google

A March Decision That Could Change Protalix BioTherapeutics Outlook

Is This Short-Term Bond ETF a Buy After Merit Financial Bought Shares Worth $8.6 Million?

Is UPS Stock a Buy Now?

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BellRing Brands, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BRBR

Oracle amps up its AI bet with a plan to raise as much as $50 billion this year

AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics

SBC Medical-Supported Medical Corporation Nasukai Forms Strategic Alliance with Daibi Medical Aesthetics

AAR Corp.: Well Positioned To Capitalize On Current Demand/Supply Dynamic

Why AT&T Stock Surged This Week

Disney may soon have a new CEO. Here's who it might be.

This Dirt Cheap Stock Is Expected to Quadruple Its Earnings This Year

OWL INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue Owl Capital

Forget Tech Stocks: The Utility That's Solving AI's Biggest Problem

Key Statistics